You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -296.7% | n/a |
| ROCE | 431.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -16.4 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 44.6 | 0.0 |
| Price / Book value | 7.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 6,000.0% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-03-31 | n/a | -0.35 | -0.58p | -3.9 | 0.0 | n/a | n/a | 0.0% |
| 2017-03-31 | n/a | -0.36 | -0.10p | -35.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-03-31 | 0.01 | -1.97 | -0.49p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-03-31 | 0.61 | -1.84 | -0.36p | -6.8 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Nuformix narrows losses as it progresses clinical programmes Sharecast News | 18 Jul |
|---|---|
| Nuformix inks cannabinoid therapeutics deal with Ebers Tech Sharecast News | 09 Apr |
| MHRA gives go-ahead to Nuformix for human studies Sharecast News | 27 Feb |
| AGM Results | 10-Sep-19 16:50 |
|---|---|
| Directorate Change | 10-Sep-19 07:05 |
| Ebers Cannabinoid Collaboration Update | 09-Sep-19 07:05 |
| Appointment of Dr Muhunthan Thillai | 06-Sep-19 07:31 |
| Holding(s) in Company | 04-Sep-19 07:31 |